|
1EJQ
SOLUTION STRUCTURE OF THE SYNDECAN-4 WHOLE CYTOPLASMIC DOMAIN IN THE PRESENCE OF PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE
Deposited 2000-03-04
|
Different construct
Different experimental conditions
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
171–198(28 aa)
Fragment:WHOLE CYTOPLASMIC DOMAIN (RESIDUES 171-198)
Chain B
171–198(28 aa)
Fragment:WHOLE CYTOPLASMIC DOMAIN (RESIDUES 171-198)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 50mM sodium phosphate;Pressure 1
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 50mM sodium phosphate;Pressure 1
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 50mM sodium phosphate;Pressure 1
NMR sample composition
2-4mM Syndecan-4 cytoplasmic domain;Molar ratio of 4:1(syndecan-4 peptide:PIP2);50mM sodium phosphate;90% H2O 10% D2O | 90% H2O/10% D2O
NMR sample composition
2-4mM Syndecan-4 cytoplasmic domain;Molar ratio of 4:1(syndecan-4 peptide:PIP2);50mM sodium phosphate;90% H2O 10% D2O | 90% H2O/10% D2O
NMR sample composition
2-4mM Syndecan-4 cytoplasmic domain;Molar ratio of 4:1(syndecan-4 peptide:PIP2);50mM sodium phosphate;90% H2O 10% D2O | 100% D2O
|
Resolution not provided
|
|
1OBY
Crystal structure of the complex of PDZ2 of syntenin with a syndecan-4 peptide.
Deposited 2003-01-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain P
193–198(6 aa)
Fragment:LAST 6 RESIDUES, RESIDUES 193-198
Chain Q
193–198(6 aa)
Fragment:LAST 6 RESIDUES, RESIDUES 193-198
|
Not recorded
|
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;SITTING DROP WITH 0.1 M HEPES, PH 6.8, 1.6 M AMMONIUM SULFATE, 20 MM COCL2, AND 0.2 MGSO4
|
Resolution 1.85 Å
R-free 0.226
|
|
1YBO
Crystal structure of the PDZ tandem of human syntenin with syndecan peptide
Deposited 2004-12-21
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
182–198(17 aa)
Chain D
182–198(17 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;20% PEG 3350, 0.2M NH4Cl, VAPOR DIFFUSION, SITTING DROP
|
Resolution 2.30 Å
R-free 0.273
|
|
8BLV
The PDZ domains of human SDCBP with a bound SDC4 C-terminal peptide
Deposited 2022-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
191–198(8 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.3;293 K;200 mM sodium sulphate, 100 mM bis-tris-propane, 10% ethylene glycol, 20% PEG 3350
|
Resolution 1.50 Å
R-free 0.222
|
|
8BLV
The PDZ domains of human SDCBP with a bound SDC4 C-terminal peptide
Deposited 2022-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
191–198(8 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.3;293 K;200 mM sodium sulphate, 100 mM bis-tris-propane, 10% ethylene glycol, 20% PEG 3350
|
Resolution 1.50 Å
R-free 0.222
|